RenovoRx RNXT Earnings Call Transcripts

NASDAQ RNXT
$1.22 +0.04 (+3.39%)
At close: Nov 11, 2026 · 4:00 PM EST
4 earnings calls on file for RenovoRx, from Q3 2025 to Q3 2026. Each transcript opens in a new tab.
Latest earnings call

RenovoRx Q3 2026 Earnings Call

Nov 5, 2026 3,475 words · 15 min read
  • Shaun BagaiChief Executive Officer
  • Dr. Ramtin AgahChief Medical Officer, Executive Chair and Founder
  • Mark VollChief Financial Officer
  • Stephanie CarringtonManaging Director of ICR Healthcare
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

RenovoRx Earnings Call Transcripts

Calls4
LatestNov 5, 2026
SinceQ3 2025

Fiscal 2026

Fiscal 2025

All 4 RenovoRx transcripts Register to get access to RenovoRx’s earnings call transcripts.